BRCA2 and breast cancer: However, these differences reached statistical significance exclusively considering the overall or ER+ BC PRS of the BRCA1 PV carriers (two-sided Welch’s t-test p≤0.04), and the ER- BC PRS of the BRCA2 PV carriers in our study sample (two-sided Welch’s t-test p<0.001).